UPC offering history
Every offering-related filing in Universe Pharmaceuticals INC’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 119 filings back to Apr 24, 2020.
| Date | Filing | What it means | |
|---|---|---|---|
| Oct 9, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 29, 2026 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Dec 9, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 25, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jun 7, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 14, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Apr 24, 2024 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
| Nov 15, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 27, 2022 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Mar 24, 2021 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Mar 22, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 10, 2021 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Mar 1, 2021 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Mar 1, 2021 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Feb 24, 2021 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Dec 10, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Dec 2, 2020 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Nov 17, 2020 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Sep 23, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Aug 17, 2020 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
UPC offering FAQ
When did UPC last execute an offering?
Per SEC filings, Universe Pharmaceuticals INC's most recent priced offering document is a 424B5 filed 2024-12-09. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did UPC last announce or register an offering?
The most recent registration is a F-3 filed 2026-09-29. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.
Free to use. No account, no card.